Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma. (Q48355928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jihyun Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jeong-Ok Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jin Ho Paik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Won Woo Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sang Eun Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

15 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

Annals of Nuclear Medicine

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Molecular pathogenesis of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Endothelin-1 induces glut1 transcription through enhanced interaction between Sp1 and NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-016-1123-6

10.1007/S12149-016-1123-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27627889%20AND%20SRC:MED&resulttype=core&format=json